A recent study revealed substantial mismatch between p16INK4a-overexpression and HPV DNA detection in VSCC and evidence arises that p16INK4a itself might function as an independent prognostic marker in vulvar cancer patients irrespective of an association with HPV (14, 15). This evidence concerns the gene CDKN2A and vulva cancer.